Safety monitoring of Breztri for COPD in Korea
Part of Lungs & breathing clinical trials.
This study tracks how well and safely Breztri (a combination inhaler medicine) works in people with COPD (a chronic lung disease) when used in real-world settings in Korea. The goal is to make sure the drug continues to be safe and effective for patients using it as prescribed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD (a long-term lung disease that makes breathing difficult)
- You recently started Breztri inhaler as your doctor prescribed it according to Korean medical guidelines
- You are willing and able to sign a consent form agreeing to participate
- You are not pregnant or breast-feeding
- You are not currently enrolled in any other medical research study that involves a new treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called BBT002 in healthy volunteers and people with chronic obstructive pulmonary disease (COPD), a lung condition that makes breathing hard. It aims to see if the drug is safe and how the body processes it.
This study checks how well COPD patients use their daily inhalers and finds ways to improve their technique. It aims to help you get the full benefit of your medication.
This trial looks at how long-term health conditions like heart disease, diabetes, or high blood pressure might affect breathing problems. The goal is to better understand and help people with both issues.
This study tests a medication called Breztri aerosphere (a triple-combination inhaler) to see how safe and well-tolerated it is in Indian patients with COPD who have had recent flare-ups. It may help people who need better control of their breathing symptoms.
This study looks at how well a triple-combination inhaler called Breztri/Trixeo works for people with moderate to severe COPD. If you have been prescribed this inhaler but haven't started it yet, and you are between 30 and 80 years old, you may be able to join.
This trial tests a remote monitoring system (BoraCare®) for people with COPD. It uses a wearable device and an early warning score to detect flare-ups early, so you can get faster care and avoid hospital stays.
Hear when a new Chronic Obstructive Pulmonary Disease (COPD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.